BIO logo

  • June 16-19, 2025
  • Boston Convention & Exhibition Center

Company Presentations Monday

Loading

Company Presentations Monday

Monday, June 03, 2024
Company Presentation Theaters
Join us in the Company Presentation Theaters on the Exhibition Floor for Company Presentations. Click through to see all of the presentations and their details.
Loading
Search Filters
  • Start time
  • Location
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
Company Presentation Theater 1
    • Other
    ReCode Therapeutics
    Company Presentation Theater 1
    Ariel Kantor
    Ariel Kantor, Head of Business and Corporate Development - ReCode Therapeutics
    • Oncology
    VerImmune Inc
    Company Presentation Theater 1
    Joshua Wang
    Joshua Wang, Founder & CEO - VerImmune Inc
    • Orphan and Rare Disease
    Rady Children's Institute for Genomic Medicine
    Company Presentation Theater 1
    Stephen Kingsmore
    Stephen Kingsmore, President & CEO - Rady Children's Institute for Genomic Medicine
    • Other
    ZTI BIOSCIENCES
    Company Presentation Theater 1
    Jaden Hyungseok Chang
    Jaden Hyungseok Chang, CEO - ZTI Biosciences
    • Oncology
    Hexagon Bio
    Company Presentation Theater 1
    Maureen Hillenmeyer
    Maureen Hillenmeyer, CEO - Hexagon Bio
    • Cell and Gene Therapy and Genome Editing
    Aurion Biotech
    Company Presentation Theater 1
    Greg Kunst
    Greg Kunst, CEO - Aurion Biotech
    • Cell and Gene Therapy and Genome Editing
    Genprex, Inc.
    Company Presentation Theater 1
    Ryan Confer
    Ryan Confer, Chief Financial Officer - Genprex, Inc.
    • Cell and Gene Therapy and Genome Editing
    Ocugen, Inc.
    Company Presentation Theater 1
    Shankar Musunuri
    Shankar Musunuri, Chairman, CEO and Co-Founder - Ocugen, Inc.
    • Cell and Gene Therapy and Genome Editing
    Protalix Biotherapeutics
    Company Presentation Theater 1
    Dror Bashan
    Dror Bashan, President, CEO - Protalix Biotherapeutics
    • Cell and Gene Therapy and Genome Editing
    Orizuru Therapeutics, Inc.
    Company Presentation Theater 1
    Shinji Ogawa
    Shinji Ogawa, Vice president and Chief Operating Officer - Orizuru Therapeutics, Inc.
    • Cell and Gene Therapy and Genome Editing
    Accuredit Therapeutics US limited
    Company Presentation Theater 1
    Yongzhong Wang
    Yongzhong Wang, CEO - Accuredit Therapeutics US Limited
    • Cell and Gene Therapy and Genome Editing
    Moonwalk Biosciences, Inc.
    Company Presentation Theater 1
    Alex Aravanis
    Alex Aravanis, CEO - Moonwalk Biosciences
    • Oncology
    Avistone Biotechnology
    Company Presentation Theater 1
    David Chung
    David Chung, Chief Business Officer - Avistone Biotechnology
    • Oncology
    Predictive Oncology
    Company Presentation Theater 1
    Raymond Vennare
    Raymond Vennare, Chief Executive Officer - Predictive Oncology
    • Oncology
    VSPharmTech
    Company Presentation Theater 1
    HO YUN NAM
    HO YUN NAM, General Manager - VSPharmTech
    • Oncology
    Reveal Pharma
    Company Presentation Theater 1
    Srini Mukundan
    Srini Mukundan, Medical Director - Reveal Pharmaceuticals Inc
    • Oncology
    QBiotics Group Limited
    Company Presentation Theater 1
    Victoria Gordon
    Victoria Gordon, Executive Director Strategic Alliances & Investor Relations - QBiotics Group Limited
    • Oncology
    KAHR Bio
    Company Presentation Theater 1
    Yaron Pereg
    Yaron Pereg, CEO - Kahr Medical Ltd.
    • Oncology
    Boryung Co., Ltd.
    Company Presentation Theater 1
    Bong Seog Kim
    Bong Seog Kim, CTO - BORYUNG CO., LTD.
    • Oncology
    Kernal Bio
    Company Presentation Theater 1
    YUSUF ERKUL
    YUSUF ERKUL, CEO - Kernal Biologics
Company Presentation Theater 2
    • Metabolic Diseases
    Hua Medicine
    Company Presentation Theater 2
    George Lin
    George Lin, EVP & Chief Strategy Officer - Hua Medicine
    • Metabolic Diseases
    Extend Biosciences
    Company Presentation Theater 2
    Tarik Soliman
    Tarik Soliman, CEO and President - Extend Biosciences
    • Metabolic Diseases
    Future Medicine
    Company Presentation Theater 2
    Jangyoun Hwang
    Jangyoun Hwang, Director - Future Medicine
    • CNS/Neurological
    AustarPharma,LLC
    Company Presentation Theater 2
    Ron Liu
    Ron Liu, CEO - AustarPharma, LLC
    • Metabolic Diseases
    Bilayer Therapeutics, Inc.
    Company Presentation Theater 2
    Thomas Collet
    Thomas Collet, President & CEO, Co-Founder - Bilayer Therapeutics, Inc.
    • Multiple Therapeutics
    Bristol Myers Squibb
    Company Presentation Theater 2
    Lauren Cautilli
    Lauren Cautilli, Manager, SBD External Event Operations - Bristol Myers Squibb
    • Multiple Therapeutics
    Johnson & Johnson
    Company Presentation Theater 2
    Stacy Feld
    Stacy Feld, Regional Head - Johnson & Johnson
    • Metabolic Diseases
    Novo Nordisk
    Company Presentation Theater 2
    Tari Suprapto
    Tari Suprapto, Director, Search & Evaluation (Western US & Canada) - Novo Nordisk
    • Multiple Therapeutics
    Amgen Inc.
    Company Presentation Theater 2
    Omari Wise
    Omari Wise, Vice President Business Development - Amgen
  10. Maryland Tech Council- BioHub Maryland
    Company Presentation Theater 2
    • Immunology
    Evaxion Biotech
    Company Presentation Theater 2
    Christian Kanstrup
    Christian Kanstrup, CEO - Evaxion Biotech
    • Immunology
    Asahi Kasei Pharma corporation
    Company Presentation Theater 2
    Takeshi Ohno
    Takeshi Ohno, Executive Officer - Asahi Kasei Pharma Corporation
    • Immunology
    Artax Biopharma
    Company Presentation Theater 2
    Christopher VanDeusen
    Christopher VanDeusen, Chief Scientific Officer - Artax Biopharma
    • Infectious Disease and Vaccines
    PlantPharm Biomed, Ltd
    Company Presentation Theater 2
    Richard Matner
    Richard Matner, President and Chief Strategy Officer - PlantPharm Biomed, Ltd
    • Immunology
    GeoVax Labs, Inc.
    Company Presentation Theater 2
    David Dodd
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
    • Immunology
    Shanghai Novamab Biopharmaceuticals Co., Ltd.
    Company Presentation Theater 2
    Yakun Wan
    Yakun Wan, CEO - Shanghai Novamab Biopharmaceuticals Co., Ltd.
    • Infectious Disease and Vaccines
    Recce Pharmaceuticals
    Company Presentation Theater 2
    James Graham
    James Graham, CEO - Recce Pharmaceuticals
    • Infectious Disease and Vaccines
    TechInvention Lifecare Pvt Ltd
    Company Presentation Theater 2
    Syed Ahmed
    Syed Ahmed, Director & CEO - Techinvention Lifecare Private Limited
    • Infectious Disease and Vaccines
    Centivax, Inc.
    Company Presentation Theater 2
    Jacob Glanville
    Jacob Glanville, Founder & CEO - Centivax
    • Infectious Disease and Vaccines
    Miracure Biotechnology
    Company Presentation Theater 2
    Xiaolin Li
    Xiaolin Li, FOUNDER/CEO - Miracure Biotechnology
Company Presentation Theater 3
    • Platform for Therapeutics
    Focal Biosciences
    Company Presentation Theater 3
    Glenn Croston
    Glenn Croston, Chief Operations Officer - Focal Biosciences
    • Multiple Therapeutics
    GenEdit
    Company Presentation Theater 3
    Barbara Leyman
    Barbara Leyman, SVP, Corporate Development - GenEdit
    • Multiple Therapeutics
    Neopharmed Gentili S.p.A.
    Company Presentation Theater 3
    Eric Falcand
    Eric Falcand, CEO - Neopharmed Gentili S.p.A.
    • Multiple Therapeutics
    Shanghai Synergy Pharmaceutical Sciences Co., Ltd., A wholly owned subsidiary of Huahai Pharmaceutical Co., Ltd.
    Company Presentation Theater 3
    Min Li
    Min Li, Board Chair - Shanghai Synergy Pharmaceutical Sciences Co., Ltd.
    • Multiple Therapeutics
    Humanetics Corporation
    Company Presentation Theater 3
    Ronald Zenk
    Ronald Zenk, Chief Executive Officer - Humanetics Corporation
    • Multiple Therapeutics
    Tharimmune, Inc.
    Company Presentation Theater 3
    Sireesh Appajosyula
    Sireesh Appajosyula, Chief Operating Officer - Tharimmune, Inc.
    • Multiple Therapeutics
    Bridge Biotherapeutics
    Company Presentation Theater 3
    Pavel Printsev
    Pavel Printsev, Director, Business Development - Bridge Biotherapeutics
    • Multiple Therapeutics
    Cellphire Therapeutics, Inc
    Company Presentation Theater 3
    Mike Gaffney
    Mike Gaffney, CEO - Cellphire Therapeutics, Inc
    • Multiple Therapeutics
    Medosome Biotec, LLC
    Company Presentation Theater 3
    Richard Wagner
    Richard Wagner, President - Medosome Biotec, LLC
    • Multiple Therapeutics
    Vivacelle Bio,Inc.
    Company Presentation Theater 3
    Cuthbert Simpkins
    Cuthbert Simpkins, President/Chief Innovation Officer - Vivacelle Bio, Inc
    • Respiratory
    Vasomune Therapeutics Inc
    Company Presentation Theater 3
    BRIAN JAHNS
    BRIAN JAHNS, President & Chief Operating Officer - Vasomune Therapeutics inc
    • Respiratory
    Inhalon Biopharma, Inc.
    Company Presentation Theater 3
    John Whelan
    John Whelan, President, CEO - Inhalon, Biopharma, Inc.
    • Pain Management
    Doloromics
    Company Presentation Theater 3
    Jackson Brougher
    Jackson Brougher, Chief Science Officer - Doloromics
    • Pain Management
    BTB Therapeutics
    Company Presentation Theater 3
    Takashi Kiyoizumi
    Takashi Kiyoizumi, CFO - BTB Therapeutics
    • Pain Management
    Virpax Pharmaceuticals, Inc.
    Company Presentation Theater 3
    Gerald Bruce
    Gerald Bruce, Chief Executive Officer - Virpax Pharmaceuticals Inc.
    • Ophthalmology
    Epion Therapeutics
    Company Presentation Theater 3
    Michael Webb
    Michael Webb, CEO - Epion Therapeutics, Inc.
    • Ophthalmology
    Neuracle Genetics
    Company Presentation Theater 3
    Sunwoo Kim
    Sunwoo Kim, Head of Business Development - Neuracle Genetics
    • Ophthalmology
    Breye Therapeutics
    Company Presentation Theater 3
    Ulrik Mouritzen
    Ulrik Mouritzen, CEO - Breye Therapeutics
    • Ophthalmology
    Lynthera Corporation
    Company Presentation Theater 3
    Jeff Yang
    Jeff Yang, President & CEO - Lynthera Corporation
    • Tools/Drug Development Support Tech
    ELEM Biotech
    Company Presentation Theater 3
    Christopher Morton
    Christopher Morton, CEO - ELEM Biotech
Company Presentation Theater 4
    • Oncology
    Pepper Bio
    Company Presentation Theater 4
    Samantha Dale Strasser
    Samantha Dale Strasser, CSO and Cofounder - Pepper Bio
    • Oncology
    Avidicure B.V.
    Company Presentation Theater 4
    Robert Friesen
    Robert Friesen, Chief Scientific Officer - Avidicure B.V.
    • Oncology
    VelaVigo
    Company Presentation Theater 4
    Tong Zhang
    Tong Zhang, Co Founder, CBO/CFO - VelaVigo
    • Oncology
    Accession Therapeutics Limited
    Company Presentation Theater 4
    Stephanie Bewick
    Stephanie Bewick, Chief Business Officer - Accession Therapuetics
    • Oncology
    Esphera SynBio Inc
    Company Presentation Theater 4
    Brian Lichty
    Brian Lichty, CEO - Esphera SynBio Inc
    • Oncology
    Glykos Finland Oy
    Company Presentation Theater 4
    Juhani Saarinen
    Juhani Saarinen, CEO - Glykos Finland Oy
    • Oncology
    StemSynergy Therapeutics
    Company Presentation Theater 4
    Dennis Fei
    Dennis Fei, Director of Drug Discovery and Development - StemSynergy Therapeutics
    • Oncology
    Lisata Therapeutics
    Company Presentation Theater 4
    David Mazzo
    David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
    • Oncology
    Osmol Therapeutics, Inc.
    Company Presentation Theater 4
    Bob Linke
    Bob Linke, President & CEO - Osmol Therapeutics, Inc.
    • Oncology
    PDX Pharmaceuticals
    Company Presentation Theater 4
    Worapol Ngamcherdtrakul
    Worapol Ngamcherdtrakul, COO - PDX Pharmaceuticals
    • Other
    Triastek, Inc.
    Company Presentation Theater 4
    Yulian Zhang
    Yulian Zhang, VP of Global BD - Triastek, Inc.
    • Platform for Therapeutics
    Rejuvenate Biomed
    Company Presentation Theater 4
    Ann Belien
    Ann Belien, Founder & CEO - Rejuvenate Biomed
    • Platform for Therapeutics
    Ceria Therapeutics, Inc.
    Company Presentation Theater 4
    David Jackson
    David Jackson, CEO - Ceria Therapeutics, Inc.
    • Platform for Therapeutics
    Avery Therapeutics, Inc.
    Company Presentation Theater 4
    Jordan Lancaster
    Jordan Lancaster, Chief Executive Officer - Avery Therapeutics, Inc.
    • Platform for Therapeutics
    Likarda, Inc
    Company Presentation Theater 4
    Stella Vnook
    Stella Vnook, CEO - Likarda
    • Platform for Therapeutics
    Varda Space Industries, Inc.
    Company Presentation Theater 4
    Mark Herbert
    Mark Herbert, Vice President, Business Development - Varda Space Industries, Inc.
    • Platform for Therapeutics
    Concerto Biosciences
    Company Presentation Theater 4
    Cheri Ackerman
    Cheri Ackerman, CEO & Cofounder - Concerto Biosciences
    • Platform for Therapeutics
    Talus Bio
    Company Presentation Theater 4
    Alex Federation
    Alex Federation, Co-Founder and CEO - Talus Bio
    • Platform for Therapeutics
    Cytotheryx
    Company Presentation Theater 4
    John Swart
    John Swart, CEO - Cytotheryx
    • Platform for Therapeutics
    Pending AI
    Company Presentation Theater 4
    David Cardoso
    David Cardoso, Vice President, Business Development and Strategy - Pending AI

 
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS

Loading

Search